14.1 CPMRS Query and Reporting

Why CPMRS is its own Competency 3.3.1 leaf

Quick Answer: CPMRS is Connecticut’s prescription drug monitoring program (PDMP), housed in DCP Drug Control under CGS § 21a-254(j). Pharmacies report Schedule II–V dispensations immediately upon, but in no event later than the next business day (DCP also: 24 hours or the next business day, whichever comes later). Gabapentin and naloxone reporting began January 1, 2021 — gabapentin is not scheduled and has no mandatory prescriber look-up. Prescribers query before a CII–V intended to last more than 72 hours, then every 90 days for ongoing CII–IV and annually for ongoing CV. Pharmacists (and authorized technicians) may query for therapy management; no person or employer shall prohibit, discourage, or impede that request.

NABP Competency 3.3.1 is not “the database exists.” It is who must look, who may look, what must be uploaded, and how fast. Chapter 7 already taught that reported ≠ scheduled. This section is the operational clock.

RCSA § 21a-254-4 still recites a twice-monthly paper-era calendar (20th and 5th). That regulation has not caught the July 1, 2016 daily-reporting statute. On the MPJE, current CGS § 21a-254(j) and DCP’s PMP pages control.

Two clocks — reporting versus query

Do not collapse upload and look-up. One is a dispenser duty into PMP Clearinghouse (pmpclearinghouse.net). The other is a user duty in PMP AWARxE (connecticut.pmpaware.net).

If CPMRS is not operational, the prescriber may still issue a >72-hour CII–V supply during the outage, but must query not more than 24 hours after regain access. That 24-hour catch-up is a prescriber sentence. It does not excuse a pharmacy from uploading yesterday’s fills when Clearinghouse is back.

What pharmacies must upload — and the 48-hour wall

DCP’s dispenser page is a checklist, not a slogan. A Connecticut-licensed pharmacy, nonresident pharmacy, hospital outpatient pharmacy, or other dispenser reports when any of the following is true:

• Schedule II–V controlled substances with a supply greater than 48 hours
• Gabapentin with a supply greater than 48 hours
• Naloxone at any prescription supply
• Insulin, glucagon, diabetes devices, and diabetic ketoacidosis devices at any supply (veterinarian products for those four diabetes categories are not reportable)

Non-reportable activities DCP lists:

• A reportable drug administered directly to a patient by a prescriber
• A licensed health-care facility dispense limited to a quantity adequate to treat at most 48 hours
• A drug sample dispensed
• Inpatient hospital or nursing-home dispensing (assisted living is not in that exemption)
• Inpatient hospice (home hospice and hospice-in-assisted-living are not exempt)
• A DEA-registered narcotic treatment program keeping records under 21 CFR 1304.24

A Saturday 30-day oxycodone fill is reportable immediately, and no later than the next business day. A 24-hour hospital discharge pack of hydromorphone can sit in the 48-hour facility exemption. Zero reports are required for days with no reportable dispensation; DCP’s waiver page says reporting is mandatory every day — open or closed, with the next-business-day catch-up when the store is actually shut. Dispensing veterinarians are the published exception: at least every seven days when they dispense more than a 48-hour CS or gabapentin supply.

January 1, 2021 added gabapentin, naloxone, and the diabetes cluster under the Commissioner’s § 21a-254(j)(2) authority to designate additional products. DCP’s notice is the exam’s favorite sentence: adding gabapentin does not change it to a controlled substance, it is not a scheduled medication, and mandatory look-up prior to prescribing does not apply. Pharmacists still upload the fill. They do not order it on a DEA 222, count it in perpetual CII, or treat a missed gabapentin query as a § 21a-254(j)(9) violation. Naloxone uploads are masked from ordinary CPMRS users; only DCP administrators see them, for aggregate policy. Do not refuse a naloxone standing-order fill because “it will show up on the patient’s report.”

Who may look — and who may not stop them

Prescriber registration with CPMRS is mandatory for anyone who holds a Connecticut controlled-substance registration (PA 13-172). The mandatory usage clock in § 21a-254(j)(9) is the prescriber’s (or authorized agent’s).

The pharmacist clock is different. A pharmacist dispensing for a patient, or that pharmacist’s authorized pharmacy technician, may obtain CPMRS information for purposes related to the pharmacist’s scope of practice and management of the patient’s drug therapy, including monitoring controlled substances the patient has obtained. PA 19-191 (effective October 1, 2019) let the designated technician register for a user account. The technician accesses the program to facilitate the pharmacist’s review. The pharmacist remains responsible, including 45 CFR 164.308 administrative safeguards, and may be disciplined for the technician’s acts.

CGS § 21a-254(j)(8) is a one-sentence employment statute: no person or employer shall prohibit, discourage, or impede a prescribing practitioner, pharmacist, or pharmacist’s authorized technician from requesting the information. A chain metric that punishes “too many PDMP looks,” a PIC who tells staff “we don’t have time for CPMRS,” or a corporate block on technician registration is the violation. Corresponding responsibility (Chapter 12) still expects the pharmacist to use the tool when red flags appear; the statute does not convert every fill into a mandatory pharmacist query the way it converts a >72-hour CII into a mandatory prescriber query.

Clinical alerts DCP publishes for users — 5 prescribers AND 5 pharmacies in 3 months, daily MME threshold, concurrent opioid plus benzodiazepine — are decision-support, not automatic refuse-to-fill rules. Interstate data include Rhode Island, Massachusetts, and New York. The State does not warrant reports as complete; call the listed pharmacy if the row looks wrong, and correct Clearinghouse errors rather than arguing with the patient about a keystroke.

Realistic Connecticut scenario

A Stamford internist writes a 10-day hydrocodone for a new outpatient. That is >72 hours, so the internist or agent must query CPMRS first. The same internist’s ongoing oxycodone for cancer pain needs a look at least every 90 days. The internist’s pregabalin (CV) for the same patient needs a look at least annually. Writing gabapentin 300 mg three times daily does not trigger the mandatory look-up, even though the New Haven pharmacy will upload that gabapentin fill by the next business day if the supply is >48 hours.

The New Haven pharmacist is not required by § 21a-254(j)(9) to query before releasing the hydrocodone, but may query, and an authorized technician may pull the report for the pharmacist. If the district manager says “CPMRS looks kill our times — stop,” § 21a-254(j)(8) is already broken. If Clearinghouse is down Saturday night, the pharmacy still owes the upload no later than the next business day after it can transmit — not the old 20th-of-the-month regulation.

Official anchors

• CGS § 21a-254 — electronic PDMP, 72-hour / 90-day / annual query, employer non-interference, reporting.
• DCP Prescriber Information — PA 15-198 and PA 16-43 query clocks; outage 24-hour catch-up.
• DCP Pharmacist / dispenser reporting — next-business-day upload; 48-hour trigger; naloxone any supply.
• DCP gabapentin / naloxone notice — reported, not scheduled; naloxone masked.
• DCP prescribing-practice highlights — 2015–2016 query cadence in DCP’s own timeline.